Alfred L. Garfall

Teclistamab in Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text

Medicine, Hematology, Immunology +17

NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma

Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl et al. · Nature Medicine · 2015 · 848 citations · Full text

Life Sciences, Immunology, Oncology +16

Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients

Thomas Condamine, George A. Dominguez, Je‐In Youn et al. · Science Immunology · 2016 · 799 citations

Medicine, Immunology, Oncology +17

B cell maturation antigen–specific CAR T cells are clinically active in multiple myeloma

Adam D. Cohen, Alfred L. Garfall, Edward A. Stadtmauer et al. · Journal of Clinical Investigation · 2019 · 790 citations · Full text

Life Sciences, Hematology, Immunology +17

IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

Vasilena Gocheva, Hao‐Wei Wang, Bedrick B. Gadea et al. · Genes & Development · 2010 · 741 citations · Full text

Medicine, Cancer Biology, Oncology +17